TCGA-G2-A3IE-01A-11R-A20F-07
—
Clinical attributes
From the source cohort, normalized into canonical keys plus the project's native columns.
- cancer_type
- —
- cancer_type_detailed
- —
- subtype
- —
- overall_survival_months
- 20.10512484
- os_event
- true
- sex
- Male
GSVA pathway preview (50 Hallmark scores)
Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.
Top 10 elevated
- BILE_ACID_METABOLISM+0.160
- KRAS_SIGNALING_DN+0.140
- APICAL_SURFACE+0.070
- PEROXISOME+0.050
- PANCREAS_BETA_CELLS+0.040
- NOTCH_SIGNALING+0.030
- SPERMATOGENESIS-0.010
- XENOBIOTIC_METABOLISM-0.010
- ESTROGEN_RESPONSE_EARLY-0.020
- ESTROGEN_RESPONSE_LATE-0.050
Top 10 suppressed
- E2F_TARGETS-0.570
- INTERFERON_ALPHA_RESPONSE-0.560
- INTERFERON_GAMMA_RESPONSE-0.500
- MYC_TARGETS_V1-0.500
- G2M_CHECKPOINT-0.480
- MTORC1_SIGNALING-0.480
- UNFOLDED_PROTEIN_RESPONSE-0.460
- TNFA_SIGNALING_VIA_NFKB-0.450
- EPITHELIAL_MESENCHYMAL_TRANSITION-0.440
- MITOTIC_SPINDLE-0.420
Patient twins — nearest pathway neighbors
10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.
9 twins match this tumor's tissue · 1 come from a different tissue of origin
| # | Sample | Cancer type | Subtype | cos similarity |
|---|---|---|---|---|
| 1 | C3N-03420 | — | cohortA1 | 0.943 |
| 2 | BS_0Y66ZBWE | low-grade glioma | — | 0.921 |
| 3 | C3N-02950 | — | cohortA1 | 0.920 |
| 4 | SRR1313097 | — | A | 0.919 |
| 5 | b03ebc32.a177.44c7.8b02.fcd6560712f2 | — | cohortA1 | 0.910 |
| 6 | SRR1516063 | — | — | 0.910 |
| 7 | SRR1516050 | — | — | 0.905 |
| 8 | TCGA-XF-A8HG-01A-11R-A36F-07 | — | — | 0.905 |
| 9 | SRR1516067 | — | — | 0.899 |
| 10 | MNG540 | — | — | 0.898 |
Per-pathway drug coverage
For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.
0 of 6 elevated pathways have at least one drug that meaningfully reverses them.
| Pathway (elevated) | tumor score | Best drug | reversal magnitude |
|---|---|---|---|
| BILE_ACID_METABOLISM | 0.160 | Inavolisib | — uncovered |
| KRAS_SIGNALING_DN | 0.140 | Remibrutinib | — uncovered |
| APICAL_SURFACE | 0.070 | Temsirolimus | — uncovered |
| PEROXISOME | 0.050 | Idelalisib | — uncovered |
| PANCREAS_BETA_CELLS | 0.040 | Cobimetinib | — uncovered |
| NOTCH_SIGNALING | 0.030 | Inavolisib | — uncovered |